Detalles de la búsqueda
1.
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination.
Int J Mol Sci
; 23(15)2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955488
2.
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC).
Molecules
; 26(4)2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567547
3.
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.
Eur J Med Chem
; 265: 116114, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194775
4.
Preomic profile of BxPC-3 cells after treatment with BRC4.
J Proteomics
; 288: 104983, 2023 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536521
5.
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy.
Front Pharmacol
; 13: 809706, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35496283
6.
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells.
Biochim Biophys Acta Gen Subj
; 1866(9): 130185, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35661802
7.
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines.
ACS Omega
; 7(46): 41872-41881, 2022 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36440117
8.
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement.
Biomedicines
; 10(6)2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740298
9.
EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/ß-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.
Cancers (Basel)
; 12(4)2020 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32290543
10.
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.
J Med Chem
; 63(5): 2588-2619, 2020 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037829
11.
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
Eur J Med Chem
; 165: 80-92, 2019 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30660828
12.
Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.
Nutrients
; 10(9)2018 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135355
13.
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Biosci Rep
; 37(3)2017 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28465354
14.
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.
ACS Chem Biol
; 12(10): 2491-2497, 2017 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841282
15.
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.
Curr Cancer Drug Targets
; 16(4): 373-85, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26278714
16.
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Clin Cancer Res
; 9(13): 4860-4, 2003 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581358
17.
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.
Biomed Res Int
; 2014: 853086, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25013807
18.
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells.
Food Chem
; 138(2-3): 1521-30, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23411276
19.
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Biosci Rep
; 31(2): 99-108, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20446926
20.
(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.
Cancer Detect Prev
; 31(6): 499-504, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18061364